MG America, the U.S. subsidiary of MG2 of Bologna, Italy, and a supplier of processing and packaging equipment, has announced a strategic alliance with life sciences equipment provider Romaco North America to cross-promote and sell complementary production machinery. The agreement synergizes machinery offerings from two key pharma industry equipment players, allowing each to offer a more comprehensive range of solutions to their respective customer bases.
Among other benefits, customers of both MG America and Romaco North America will see enhanced equipment servicing options; combined, the two companies can deploy more than a dozen field service technicians in various geographies throughout the U.S. and Canada. Each company is also able to leverage the other’s industry reputation while offering a wider range of equipment.
While both companies offer multidisciplined product lineups, the alliance largely focuses on complementary solutions. For instance, MG America will now be offering its customers several packaging platforms from Romaco, including popular cartoners such as the Promatic P 91 intermittent motion and Promatic PC 4000 continuous motion models. On the processing side, MG America will also be showcasing Romaco’s Kilian series of tablet presses, along with a variety of sophisticated coating and granulation equipment.
In turn, Romaco will highlight MG America’s full line of capsule filling machinery – including the recently introduced Essentia, a compact, versatile unit suitable for medium- to large-batch manufacturing that offers minimal production floorspace allocation, easy cleaning, and simplified maintenance. Romaco will also be able to sell a wide range of MG America packaging equipment, including case packers, tray formers, sachet machines and palletizers.
“Teaming up with our friends at Romaco provides an immediate, turnkey array of solutions that align with and supplement our own equipment portfolio,” said Claudio Radossi, President of MG America. “Synergistic relationships are designed to make all parties stronger, and this agreement certainly accomplishes that — not only for Romaco and MG America but for our growing, evolving customer bases.”
Sabri Demirel, Managing Director for Romaco North America, agreed, saying, “Combining our strengths allows each company not only to expand its portfolio with proven, highly regarded solutions, but also to grow the resources we have in the sales and servicing field. This alliance takes two companies with decades in the market and strong name recognition and makes them even more attractive to pharma manufacturers and other customers.”
